Search research articles
Contact Us
Filters
Showing results (1-10 of 80) with videos related to
Page
of 8
Sort By:
The Journal of Allergy and Clinical Immunology
|
June 9, 1999
Pressurized metered-dose inhalers and holding chambers for inhaled glucocorticoid therapy in childhood asthma
B K Rubin
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine
|
January 2, 1997
Therapeutic aerosols and airway secretions
B K Rubin
Critical Care Medicine
|
September 29, 2000
The well-stressed intensivist
B K Rubin
Pediatric Infectious Disease
|
November 1, 1983
"Cephalomalacia obfuscate," a fourth generation cephalosporin
B K Rubin
Pediatric Pulmonology
|
February 19, 1999
Who will benefit from DNase?
B K Rubin
Chest
|
July 29, 1999
An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol
B K Rubin
Chest
|
April 20, 1999
Emerging therapies for cystic fibrosis lung disease
B K Rubin
Chest
|
December 1, 1996
Of no significant benefit
B K Rubin
Respiratory Care
|
July 14, 2000
Experimental macromolecular aerosol therapy
B K Rubin
Pediatric Infectious Disease
|
January 1, 1985
The evaluation of the child with recurrent chest infections
B K Rubin
Page
of 8
Search research articles
Search
Showing results (1-10 of 80) with videos related to
Sort By:
Page
of 8
The Journal of Allergy and Clinical Immunology
|
June 9, 1999
Pressurized metered-dose inhalers and holding chambers for inhaled glucocorticoid therapy in childhood asthma
B K Rubin
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine
|
January 2, 1997
Therapeutic aerosols and airway secretions
B K Rubin
Critical Care Medicine
|
September 29, 2000
The well-stressed intensivist
B K Rubin
Pediatric Infectious Disease
|
November 1, 1983
"Cephalomalacia obfuscate," a fourth generation cephalosporin
B K Rubin
Pediatric Pulmonology
|
February 19, 1999
Who will benefit from DNase?
B K Rubin
Chest
|
July 29, 1999
An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol
B K Rubin
Chest
|
April 20, 1999
Emerging therapies for cystic fibrosis lung disease
B K Rubin
Chest
|
December 1, 1996
Of no significant benefit
B K Rubin
Respiratory Care
|
July 14, 2000
Experimental macromolecular aerosol therapy
B K Rubin
Pediatric Infectious Disease
|
January 1, 1985
The evaluation of the child with recurrent chest infections
B K Rubin
Page
of 8